Kamada

Share on: 
Website: Kamada
Description: 

They focus on plasma-derived protein therapeutics for treatment of individuals with rare diseases and unmet medical needs.

COVID-19: (04/28/20) - Kamada and Kedrion Biopharma of Italy will work together to develop, manufacture and distribute a polyclonal immunoglobulin product as a potential COVID-19 treatment to be produced using Kamada's proprietary IgG platform technology.

Location(s): 
Negev
Israel